Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation (RSC Adv. (2023) 13 (9513–9529) DOI: 10.1039/D3RA00526G)

Sunil Kumar; Amritha Manoharan; J. Jayalakshmi; Mohamed A. Abdelgawad; Wael A. Mahdi; Sultan Alshehri; Mohammed M. Ghoneim; Leena K. Pappachen; Subin Mary Zachariah; T. P. Aneesh; Bijo Mathew

ArticleOPEN ACCESS

Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation (RSC Adv. (2023) 13 (9513–9529) DOI: 10.1039/D3RA00526G)

RSC Advances

DOI: 10.1039/d3ra90030d

0Citations

6Readers

Abstract

The authors regret that the email addresses were associated with the incorrect institution. The corrected association is as shown above. The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.

Cite

CITATION STYLE

APA

Kumar, S., Manoharan, A., Jayalakshmi, J., Abdelgawad, M. A., Mahdi, W. A., Alshehri, S., … Mathew, B. (2023, April 6). Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation (RSC Adv. (2023) 13 (9513–9529) DOI: 10.1039/D3RA00526G). RSC Advances. Royal Society of Chemistry. https://doi.org/10.1039/d3ra90030d

Correction: Exploiting butyrylcholinesterase inhibitors through a combined 3-D pharmacophore modeling, QSAR, molecular docking, and molecular dynamics investigation (RSC Adv. (2023) 13 (9513–9529) DOI: 10.1039/D3RA00526G)

Abstract

Cite

Register to see more suggestions